BackNovartis AG Overview

Novartis AG Inventory

Latest inventory for NVS: $6.2B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$6.21B
↓ 1.59% YoYΔ $-100.02M vs prior year quarter

Peer trimmed avg / median

Loading

Novartis AG Inventory History

Loading

Novartis AG vs. peers: Inventory Comparison

Loading

Novartis AG Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novartis AG (NVS) FAQ

As of the most recent data (June 2026), NVS shows a inventory of $6.2B. That compares with $6.3B in the prior-year period — down 1.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVS's inventory is now $6.2B (was $6.3B) — a 1.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Novartis AG is outperforming or lagging.

Tracking NVS's inventory over time shows whether Novartis AG is scaling, shrinking, or reshaping that part of the business. The current reading is $6.2B That compares with $6.3B in the prior-year period — down 1.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $6.2B) with ownership activity and broader fundamentals.

Novartis AG's inventory is $6.2B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.